首页 蛋白库 基因库 产品 会员服务
位置：首页 > 产品库 > Altrenogest
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
Altrenogest
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
Altrenogest图片
CAS NO:850-52-2
包装与价格：
包装价格(元)
10mM (in 1mL DMSO)询价
50mg询价

Altrenogest (Allyltrenbolone) 是一种结构上与兽用类固醇群勃龙相关的孕激素。
Cas No.850-52-2
别名四烯雌酮,Allyltrenbolone; RU2267
化学名(8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Canonical SMILESCC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(CC=C)O
分子式C21H26O2
分子量310.43
溶解度≥ 14.4mg/mL in DMSO
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone.

Altrenogest (Allyltrenbolone) is a progestogen structurally related to veterinary steroid trenbolone. Treatment of embryo-recipient mares with Altrenogest (Allyltrenbolone) appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer[1]. The oil and gel Altrenogest (Allyltrenbolone) preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest (Allyltrenbolone) treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL[2].

References:
[1]. Parry-Weeks, L.C. and D.W. Holtan, Effect of altrenogest on pregnancy maintenance in unsynchronized equine embryo recipients. J Reprod Fertil Suppl, 1987. 35: p. 433-8.
[2]. Daels, P.F., et al., Persistence of the luteal phase following ovulation during altrenogest treatment in mares. Theriogenology, 1996. 46(5): p. 799-811.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024